• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • Our Services
  • Contact Us
  • Newsletter
  • Top Nav Social Icons

Mobile ID World

Mobile ID World

Identification Revolution

  • Mobile ID
    • What Is Mobile ID?
    • Identity Associations
    • Premier Partners
    • FAQ
  • News
  • Solutions
    • Behavioral
    • Facial Recognition
    • Fingerprint Biometrics
    • Iris Biometrics
    • Second Factor
    • Smart Cards
    • Smartphones
    • Vital
    • Voice
    • Wearable Tech
    • Other
  • Applications
    • Access Control
    • Cloud Technology
    • Commerce
    • Enterprise
    • Healthcare
    • Identification
    • Internet of Things
    • Law Enforcement
    • Strong Online Authentication
  • Exclusive
    • Interviews
    • Featured Articles
    • Podcasts
  • Companies
  • Events

Recardio Announces Rollout of CardioCare Across Europe

November 7, 2019

Recardio Announces Rollout of CardioCare Across Europe

Life sciences company Recardio Inc. has announced the rollout of its CardioCare platform across Europe, beginning with more than half a dozen countries, in support of its clinical development programs in cardiovascular health.

Recardio’s CardioCare platform was recognized at the European Society of Cardiologists Congress (ESC) in 2018 in Munich, Germany, and has now seen adoption by clinicians across a number of countries in Europe including Austria, Hungary, Poland, Bulgaria, Netherlands, Belgium and Germany.

“Recardio’s digital platform CardioCare is now available throughout Europe and will be integrated into future clinical development programs like the upcoming global Phase 3 program,” said Harald Kattnig, Project Manager for CardioCare and Vice President Information Systems at Recardio. 

The platform, which can be used in connection with a number of FDA-approved wearable devices, captures a patient’s heart data, feedback and biometrics for analysis. The data that is captured can be used to treat patients or for future clinical studies in the field of cardiovascular health.

CardioCare effectively combines mobile applications, artificial intelligence, and wearable technologies in the growing field of digital medicine and combines them to provide a platform for personalized therapy and clinical trials.

Recardio’s cardiovascular care programs are in their clinical stage — Phase 2 — and the release of CardioCare looks to aid them in reaching the next phase. Phase 3 will involve the further development of their therapeutic platform with the aim of providing treatment for patients with various cardiovascular diseases including myocardial infarction and heart failure.

Filed Under: Industry News Tagged With: Artificial Intelligence, Biometric, biometrics, clinical care, data analytics, heart rate monitoring, heart rate tracking, medical biometrics, wearable biometrics, wearables

Related News & Articles

FotoNation Banks on VR Excitement with New Iris Solution for Headsets

UBC Researchers Develop Washable Battery for Wearables

Samsung Money Goes Live in the U.S.

Primary Sidebar

Register For the Next Virtual Identity Summit

Register now!

Tweets

Sponsored Links

FACEPHI is a global leader in Facial Recognition technology and in Mobile Biometrics technologies. With a strong concentration in the financial sector, FacePhi's product is rapidly becoming a service used by banks all over the world. Its implementation doesn’t just save money, it is also a way to attract clients and build loyalty, while increasing the security of transactions for both the customer and the business. To learn more about FacePhi, visit https://www.facephi.com/en/

Recent Posts

  • FPC’s Optical In-display Sensor Gets First Design Win
  • FCC Tells Apple and Google to Get Rid of TikTok
  • Yubico Offers Subscriptions Through AWS Marketplace
  • Saskatchewan Privacy Commissioner Urges Development of Optional Digital ID
  • Wearable Authentication Company Closes $13 Million Funding Round

Footer

  • About Us
  • Company Directory
  • Advertise With Us
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • Archives
  • CCPA: Do not sell my personal info.

Follow Us

Copyright © 2022 MobileIDWorld